How GHK-Cu Benefits Skin & Hair

What Is GHK-Cu?

GHK-Cu is a copper-binding peptide found in human plasma. Discovered in 1973, it is a protective and regenerative substance commonly found in skin and hair products. It has demonstrated effects in tissue repair as well as effects that are anti-inflammatory, anti-cancer, anti-anxiety, and anti-pain (1).

How It Works (Mechanism of Action)

Much of GHK’s effects are likely due to its action in binding copper ions and its role in copper metabolism. However, recent advancements in genetic research indicate that GHK-Cu also regulates many human genes and thus is involved in gene expression. As many as 31.2% of human genes are affected by GHK with a change of greater than 50%. As such, GHK-CU is able to exert effects on skin regeneration, blood vessel and nerve growth, anti-cancer mechanisms, and more (1).

What Does the Research Show?

GHK-Cu has several beneficial effects supported by research, including:

• Skin regeneration. Several experiments have shown that GHK stimulates collagen synthesis and exerts a regulatory effect on protein breakdown within the skin, preventing damaged protein buildup. Additionally, it can benefit skin fibroblasts, which are essential to skin regeneration.
• Cosmetics. Multiple clinical studies have demonstrated that GHK-Cu can provide cosmetic improvements in aging skin. For example, when applied for 12 weeks via facial cream to 71 aging women, skin quality was increased.
• Nerve and blood vessel growth. During tissue repair, GHK is released from the SPARC protein to stimulate new blood vessel development. GHK can also stimulate nerve growth during skin repair.
• Lung repair. In vitro, GHK-treated lung fibroblasts from COPD treatments demonstrated restoration of function. GHK-CU treated mice were also protected from induced acute lung injury.
• Anti-cancer effects. GHK has been shown to affect 84 genes that are associated with DNA repair, thus exhibiting anti-cancer effects. In a 1983 study in mice, CHK-Cu suppressed cancer (1).

Clinical Relevance (Real-World Perspective)

When it comes to cosmetic applications of GHK-Cu, there is some evidence that GHK-Cu could be of benefit in the form of topical creams and serums. Thus, individuals may opt to include this ingredient into their skin routine. However, larger scale clinical trials that assess GHK-Cu’s utility systemically and in other medical indications are needed to fully categorize it’s clinical benefit.

Safety, Regulation, and Quality Concerns

GHK-Cu is not approved by the US Food and Drug Administration (FDA) as a drug. However, when used in cosmetic formulations, it is categorized as a cosmetic and thus falls under a different regulatory category.

GHK-Cu is not currently eligible for 503A/503B compounding but is currently a category 2 bulk substance nominated under 503A or 503B. It has some safety concerns associated with its use (2).

Potential Risks and Side Effects

Compounded injectable drugs that contain GHK-Cu are thought to carry an immunogenicity risk. This is due to the possibility of aggregation and peptide-related impurities. Additionally, data in humans is limited and thus the safety profile not well-categorized (2).

Practical Takeaways

The use of GHK-Cu is accessible via the topical route for cosmetic purposes, which is supported by some preliminary clinical evidence. However, further research is required for other indications, and it is not currently approved by the FDA as a drug.

Bottom Line Medical & Regulatory Disclaimer

The information provided in this article is for educational purposes only and is not intended as medical advice. Many peptides are not FDA-approved for human use outside of limited clinical contexts. These compounds are often obtained through unregulated sources that lack quality control. Studies suggest 30–65% of products may be contaminated or mislabeled, with risks including endotoxins, heavy metals, and incorrect sequences. At Weight Loss & Vitality, we focus on evidence-based, medically supervised therapies.

References

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
2. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks#:~:text=Compounded%20drugs%20containing%20epitalon%20may%20pose%20risk,would%20cause%20harm%20if%20administered%20to%20humans.

Author

David J. Bauder, PA-C David Bauder, PA-C, is a certified physician assistant and the assistant medical director at Weight Loss and Vitality in Manassas and Alexandria, Virginia, Washington, DC; and Gaithersburg, MD. He enjoys helping patients optimize their physical and mental health to improve their overall well-being. He earned his physician assistant degree from the University of Texas Health Science Center at San Antonio. Afterward, he gained admission into the reputable graduate program for physician assistant studies at the University of Nebraska Health Science Center in Omaha. David has over 26 years of experience working as a physician assistant. He’s practiced in podiatry, family medicine, emergency medicine, general surgery, urgent care, and functional medicine.